Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
What Is Intestinal Cancer Metastasis? Stages, Treatment & Prognosis.
What Is Intestinal Cancer Metastasis? Stages, Treatment & Prognosis. 4

Getting a stage 4 disease diagnosis can be very scary. This is known as intestinal cancer metastasis. It happens when cancer cells move from the colon or rectum to other parts of the body.

About 20 percent of people find out they have this at their first doctor’s visit. You are not alone in this journey. Our team is here to help you understand and deal with these tough medical issues.

We at MCRC healthcare use the latest medical knowledge and care with kindness. We aim to make treatments better and improve life quality for everyone we help.

Key Takeaways

  • Stage 4 disease occurs when cells spread from the colon or rectum to other parts of the body.
  • About one in five patients face this diagnosis at their first medical evaluation.
  • Multidisciplinary care teams are essential for managing advanced health conditions effectively.
  • Recent medical innovations have significantly improved survival rates and treatment options.
  • Choosing a dedicated healthcare partner ensures you receive personalized guidance throughout your recovery.

Understanding Intestinal Cancer Metastasis

Apr 1447 image 2 LIV Hospital
What Is Intestinal Cancer Metastasis? Stages, Treatment & Prognosis. 5

We aim to make the spread of intestinal cancer clear. This helps during tough times. Knowing how the disease moves lets us prepare and make care choices.

Defining Metastatic Colorectal Cancer

Cancer cells can leave the original tumor in the colon or rectum. They travel through the bloodstream or lymph system to other parts of the body. This is called crc metastatic colorectal cancer.

You might see crc medical abbreviation in medical reports. It means the disease has spread.

Doctors call this stage etastatic colorectal cancer mcrc. It means treatment needs to be more thorough and widespread.

Prevalence and Initial Diagnosis Statistics

Many patients are diagnosed early, when the disease is only in the colon or rectum. But, it’s key to stay alert during recovery.

About 25 percent of those with early disease will develop metastases later. This shows why follow-up care and monitoring are so important.

Common Sites of Spread

The spread of cancer, or rc metastasis, often follows certain paths. The liver is the most common place for secondary tumors because of its connection to the colon.

This pattern affects about 50 percent of patients with advanced disease. Other common places include:

  • The lungs
  • The peritoneum (the lining of the abdominal cavity)
  • Distant lymph nodes

Knowing these patterns helps doctors create effective strategies. We support you every step of the way with care and knowledge.

Clinical Progression, Survival, and Treatment Approaches

Apr 1447 image 3 LIV Hospital
What Is Intestinal Cancer Metastasis? Stages, Treatment & Prognosis. 6

The outlook for metastatic colorectal cancer has improved a lot in recent years. Getting a diagnosis of metastatic CRC can be tough, but medical science is making big strides. Doctors are now focusing on personalized care, helping patients with more precision and hope.

Trends in Survival Rates and Prognosis

Knowing the stats is key to healing. The five-year survival rate for metastatic colorectal cancer is 15.6 percent. This shows a global effort to improve survival rates.

In the last 20 years, we’ve seen big progress. The median survival time has gone up from 22.6 months to 32.4 months. This shows how well modern treatments work against crc cancer.

Modern Treatment Modalities

Doctors now have many treatment options for what is metastatic colorectal cancer mcrc. They use a mix of therapies based on the tumor’s genetic profile. Our aim is to give the best care while keeping quality of life high.

The main treatments are:

  • Surgery: Used to remove tumors in the colon or distant sites when possible.
  • Chemotherapy: Treatments that target and shrink cancer cells.
  • Targeted Therapy: Medications that attack specific proteins or pathways in cancer cells.
  • Immunotherapy: Treatments that help the body’s immune system fight cancer.

We keep improving our metastatic CRC treatment plans. We’re here to support you with the latest medical insights and care as you explore these options.

Conclusion

Getting a diagnosis of advanced metastatic colorectal cancer means you need to know your options. We say metastatic colorectal cancer is a condition that needs a custom plan. Our team works to give you the facts so you can make informed choices.

Today’s medicine has many tools to fight advanced metastatic colon cancer. We use surgery, chemotherapy, targeted therapy, and immunotherapy. These treatments help us tackle metastatic colon cancer and improve your life quality.

Learning about metastatic colorectal cancer can be tough. It’s important to talk to your healthcare team. They can explain how these treatments fit your health needs. Whether it’s about managing metastatic bowel cancer or understanding meta crc, we’re here to support you.

Dealing with advanced colorectal cancer is a team effort. We’re here to guide you every step of the way. Contact our experts to create a care plan that meets your specific needs for colon cancer metastasis or advanced metastatic colorectal cancer.

Managing etastatic colon cancer or etastatic bowel cancer is a journey we take together. Your health is our top priority as we explore new treatments. Contact our center to start your personalized care plan today.

FAQ:

How do medical professionals define metastatic colorectal cancer?

Metastatic colorectal cancer refers to cancer that starts in the colon or rectum and spreads to distant organs or tissues. It is a later stage of Colorectal Cancer, where cancer cells have moved beyond the original site through the bloodstream or lymphatic system and formed new tumors elsewhere in the body.

What are the primary facts about metastatic colorectal cancer regarding diagnosis?

Diagnosis involves confirming the primary tumor in the colon or rectum and identifying spread to other organs through imaging tests such as CT scans, MRI, or PET scans, along with blood tests like CEA (carcinoembryonic antigen). A biopsy of either the primary tumor or metastatic site is used to confirm the diagnosis of Colorectal Cancer and its metastatic nature.

Which organs are most commonly affected by colon cancer metastasis?

The most common sites of spread are the liver, lungs, and peritoneum (lining of the abdominal cavity). The liver is particularly frequent because blood from the intestines flows directly to it through the portal circulation.

What is the current prognosis for those seeking treatment for metastatic bowel cancer?

The prognosis for metastatic Colorectal Cancer varies depending on how far the disease has spread, the patient’s overall health, and how well the cancer responds to treatment. While it is generally not considered curable in advanced stages, survival has improved significantly with modern therapies, and some patients can live several years with controlled disease.

What modern modalities are used to treat advanced metastatic colorectal cancer?

Treatment typically includes systemic chemotherapy (such as combination regimens), targeted therapies that block specific cancer pathways, and immunotherapy for selected genetic subtypes. In some cases, surgery or ablation of metastases (especially in the liver or lungs) may be possible. Other options include radiation therapy and localized treatments like hepatic artery infusion in specialized centers. A multidisciplinary approach is used to tailor treatment for Colorectal Cancer based on genetic and clinical factors.

References:

 National Center for Biotechnology Information. https://pubmed.ncbi.nlm.nih.gov/27380959/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 04